Dobi; Albert

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dobi; Albert.The latest application filed is for "lipid, protein, and metabolite markers for the diagnosis and treatment of prostate cancer".

Company Profile

6.8.13

Dobi; Albert - Rockville MD
Dobi; Albert - Columbia MD US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Lipid, Protein, And Metabolite Markers For The Diagnosis And Treatment Of Prostate Cancer App 20220107322 - Kiebish; Michael Andrew ; et al.	2022-04-07
Genomic Rearrangements Associated With Prostate Cancer And Methods Of Using The Same App 20220033913 - DOBI; Albert ; et al.	2022-02-03
Markers For The Diagnosis Of Prostate Cancer App 20210080466 - Kiebish; Michael Andrew ; et al.	2021-03-18
Markers For The Diagnosis Of Biochemical Recurrence In Prostate Cancer App 20200292548 - Kiebish; Michael Andrew ; et al.	2020-09-17
Genomic rearrangements associated with prostate cancer and methods of using the same Grant 10,711,311 - Srivastava , et al.	2020-07-14
Erg Monoclonal Antibodies App 20190185576 - Srivastava; Shiv ; et al.	2019-06-20
Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations Grant 10,287,587 - Srivastava , et al.	2019-05-14
Lipid, Protein, And Metabolite Markers For The Diagnosis And Treatment Of Prostate Cancer App 20180024132 - Kiebish; Michael Andrew ; et al.	2018-01-25
Genomic Rearrangements Associated With Prostate Cancer And Methods Of Using The Same App 20160326595 - Srivastava; Shiv K. ; et al.	2016-11-10
Prostate Cancer Gene Profiles And Methods Of Using The Same App 20160326594 - Srivastava; Shiv K. ; et al.	2016-11-10
Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations Grant 9,206,481 - Srivastava , et al. December 8, 2	2015-12-08
Prostate Cancer-specific Alterations In Erg Gene Expression And Detection And Treatment Methods Based On Those Alterations App 20150044670 - Srivastava; Shiv ; et al.	2015-02-12
Erg Monoclonal Antibodies App 20140370023 - Srivastava; Shiv ; et al.	2014-12-18
ERG monoclonal antibodies Grant 8,765,916 - Srivastava , et al. July 1, 2	2014-07-01
Prostate cancer-specific alternations in ERG gene expression and detection and treatment methods based on those alterations Grant 8,541,169 - Srivastava , et al. September 24, 2	2013-09-24
Erg Monoclonal Antibodies App 20120135018 - Srivastava; Shiv ; et al.	2012-05-31
Prostate Cancer-Specific Alternations in ERG Gene Expression and Detection and Treatment Methods Based on Those Alterations App 20100144832 - Srivastava; Shiv ; et al.	2010-06-10
Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations App 20080269157 - Srivastava; Shiv ; et al.	2008-10-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.